Consequences of revised CLSI and EUCAST guidelines for antibiotic susceptibility patterns of ESBL- and AmpC β-lactamase-producing clinical Enterobacteriaceae isolates
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.